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Abstract
Medium spiny neurons (MSNs) comprise the vast majority of neu-
rons in the striatum. Changes in the exuberant dendrites of these
widely connected neurons are associated with a multitude of neuro-
logical conditions and are caused by a variety of recreational and
medicinal drugs. However, we have a poor understanding of the
physiological regulators of dendrite growth and elaboration of this
clinically important population of neurons. Here, we show that MSN
dendrites are markedly smaller and less branched in neonatal mice
that possess a homozygous null mutation in the neuregulin-4 gene
(Nrg4/) compared with wild type (Nrg4þ/þ) littermates. Nrg4/
mice also had a highly significant reduction in MSN dendrite spine
number in neonates and adults. The striking stunted dendrite arbor
phenotype of MSNs observed in Nrg4/ neonates was replicated in
MSNs cultured from Nrg4/ embryos and was completely rescued
by soluble recombinant neuregulin-4. MSNs cultured from wild type
mice coexpressed NRG4 and its receptor ErbB4. Our findings show
that NRG4 is a major novel regulator of dendritic growth and arbori-
zation and spine formation in the striatum and suggest that it exerts
its effects by an autocrine/paracrine mechanism.
Key Words: Dendrites, Medium spiny neurons, Neuregulin-4,
Striatum.
INTRODUCTION
Medium spiny neurons (MSNs) comprise 90%–95% of
the neurons in the striatum. These GABAergic inhibitory neu-
rons have exuberant dendritic arbors that are densely studded
with dendritic spines. They receive large numbers of afferents
from major brain regions, including extensive glutaminergic
input from the cortex, hippocampus, amygdala, and thalamus
and dopaminergic input from the ventral tegmental area and
substantia nigra (1). MSNs are projection neurons whose
axons terminate in the substantia nigra and globus pallidus (2).
Because of their extensive and unique connections, MSNs
play a central role in the control of voluntary movement, pro-
cedural memory and motivated behavior (3). Degeneration
and loss of MSNs is the pathognomonic feature of Huntington
disease and underlies the symptomology of this hereditary
neurodegenerative disorder (4). In addition to Huntington dis-
ease, dendritic changes in MSNs are associated with a range
of neurological disorders, including Parkinson disease, dysto-
nia, compulsivity, addiction, hyperactivity, and depression (2,
5–9). Because dendrite morphology and spine density are key
determinants of the functional properties of neurons and neu-
ral circuits in health and disease, the changes in MSN den-
drites in so many neurological disorders emphasize the need
to understand the physiological regulators of MSN dendrite
morphology and the formation of dendrite spines.
While administration of drugs, such as nicotine, cocaine,
and neurotransmitter receptor agonists and antagonists, to
rodents is associated with changes in MSN dendrite morphol-
ogy and spine density (7, 10), the clearest evidence for physio-
logically relevance of particular proteins controlling striatal
MSN dendrite morphology has come from studies of trans-
genic manipulation of the expression of particular proteins.
For example, decreased MSN spine density has been reported
in mice that are heterozygous for a null mutation in bdnf gene
(11) and in mice that lack the diacylglycerol kinase-b gene
(12). Decreased MSN dendritic arborization has been reported
in mice that overexpress dopamine D2 receptors in MSNs
(13). Conversely, increased MSN dendritic arborization has
been reported in mice that lack the Cd40 gene, and in vitro
experiments suggest that CD40-activated CD40L reverse sig-
naling suppresses MSN dendrite growth and elaboration by a
PKCc-dependent mechanism (14).
Here, we have investigated the role of neuregulin-4
(NRG4) in regulating the growth and elaboration of MSN den-
drites and dendrite spine formation in developing mice. NRG4
is one of the neuregulins that are widely expressed pleiotropic
growth factors related to epidermal growth factor that signal
via the ErbB family of receptor tyrosine kinases (15). The neu-
regulins, especially the numerous isoforms of NRG1, have nu-
merous roles in the development and function of neurons and
glia, including regulating the assembly of neural circuitry,
myelination, neurotransmission, and synaptic plasticity (16).
Importantly, the Nrg1, Nrg2, Nrg3, ErbB3, and ErbB4 genes
have been identified as susceptibility genes for schizophrenia,
depression, and bipolar disorder (16, 17) and numerous
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genetic and functional studies have directly implicated the
Nrg1, Nrg2, Nrg3, and ErbB4 genes in the development of
psychotic behavior (18–22). Unlike other neuregulins, NRG4
is expressed at much lower levels in the brain, and only one
function has been described for this factor in the brain so far.
The dendrites of neocortical pyramidal neurons of Nrg4/
mice are stunted compared with wild type mice, suggesting
that NRG4 regulates dendritic arborization in the developing
cerebral cortex (23). In the present study, we have compared
the striatal MSNs of Nrg4þ/þ and Nrg4/ mice. We show
that striatal MSN dendrites are markedly smaller and less
branched in NRG4-deficient mice compared with those of
wild type mice in vivo and in vitro and have a greatly reduced
number of dendritic spines, suggesting that NRG4 plays a ma-
jor novel role in dendrite development from this clinically im-
portant population of neurons.
MATERIALS ANDMETHODS
Animals
Mice were housed in a 12-hour light-dark cycle with ac-
cess to food and water ad libitum. Breeding was approved by
the Cardiff University Ethical Review Board and was per-
formed within the guidelines of the Home Office Animals
(Scientific Procedures) Act, 1986. Nrg4 null mice in which the
Nrg4 locus was disrupted by retroviral insertion of a gene trap
between exons 1 and 2 were purchased from the Mutant
Mouse Resource Center, UC Davis (Davis, CA). These mice
were backcrossed from a C57/BL6 background into a CD1
background. Nrg4þ/ mice were crossed to generate Nrg4þ/þ
and Nrg4/ littermates.
Neuron Culture
MSN cultures were prepared from E14 striatal primor-
dia that were triturated to produce a single cell suspension fol-
lowing trypsin digestion (Worthington, Lakewood, NJ) and
DNase I treatment (Roche Applied Science, Burgess Hill,
UK). To increase the yield of MSN and avoid contamination
with other regions, striata were thoroughly cleaned after dis-
section and cells were grown in a media that promotes neuro-
nal growth while preventing the growth of other
nondifferentiated cells. Neurons were plated at a density of
15 000 cells/cm2 at the center of 35-mm dishes coated with
poly-L-lysine (Sigma-Aldrich, Gillingham, UK). Cells were
cultured with Neurobasal A (Invitrogen, Paisley, UK) supple-
mented with 2% B27 (Invitrogen), 1% fetal calf serum
(Sigma-Aldrich), 100 units/mL penicillin and 100lg/mL
streptomycin (Gibco BRL, UK). To avoid extensive astrocyte
proliferation, the medium was changed to medium without fe-
tal calf serum after 7 days in vitro. The cultures were incubated
at 37C in a humidified atmosphere containing 5% CO2 and
were treated with recombinant human NRG4 (Thermo Fisher
Scientific) the same day after plating, as indicated. No other
growth factors were added to the medium. The culture me-
dium was partially replaced with fresh medium with the treat-
ments after 4–5 days. The cultures were fixed 10 or 12 days
after plating.
Immunocytochemistry
After 10–12-day in vitro, neurons were fixed for
10 minutes in 4% paraformaldehyde in 0.12 M phosphate-
buffered saline (PBS), washed 3 times in PBS, and blocked in
1% bovine serum albumin (Sigma), 0.1% Triton (Sigma) in
PBS for 1 hour, then incubated with primary antibodies against
either NRG4 (1:200, goat-polyclonal, Santa Cruz), ErbB4
(1:200, rabbit or mouse-monoclonal, Abcam, Cambridge,
MA), DARPP-32 (1:400, rabbit-monoclonal, Cell Signaling
Technology, Danvers, MA) or bIII-tubulin (1:500, mouse-
monoclonal, R&D Systems) at 4C overnight. After washing,
the neurons were incubated with polyclonal Alexa-conjugated
secondary antibodies (donkey anti-goat Alexa-546, donkey
anti-rabbit Alexa-488, Invitrogen) 1:500 for 1 hour at room
temperature. Cells were then washed, incubated with DAPI
(1:8000) and visualized using a Zeiss LSM710 confocal mi-
croscope. For double immunolabeling, the cultures were incu-
bated simultaneously with both primary and secondary
antibodies.
Quantification of Dendrite Morphology In Vitro
Total neurite length, the number of branching points and
Sholl analysis was performed on DARPP-32-positive neurons.
The soma was labeled with anti-bIII-tubulin and the length
was quantified using FIJI (Image J) as previously described
(23).
Immunohistochemistry
Brains were fixed overnight using 4% paraformaldehyde
in 0.12 M PBS at 4C, washed in PBS and cryoprotected in
30% sucrose before being frozen in dry ice-cooled isopentane.
Serial 30 lm sections were blocked in 1% bovine serum albu-
min (Sigma), 0.1% Triton (Sigma) in PBS and then incubated
with 1:400 rabbit-monoclonal anti-DARPP32 (Cell Signaling)
and 1:200 goat-polyclonal anti-NRG4 (Santa Cruz Biotech-
nologies, Santa Cruz, CA) antibodies at 4C overnight. After
washing, the sections were incubated with 1:500 of donkey
anti-rabbit or goat-polyclonal Alexa-488 or Alexa-647 conju-
gated secondary antibodies (Invitrogen) for 1 hour at room
temperature. Sections were washed, incubated with DAPI, and
visualized using a Zeiss LSM710 confocal microscope.
Quantitative PCR
The levels of Nrg4 and ErbB4 mRNAs in the striatum
were quantified by RT-qPCR relative to a geometric mean of
mRNAs for the house keeping enzymes glyceraldehyde phos-
phate dehydrogenase (Gapdh mRNA), succinate dehydroge-
nase (Sdha mRNA), and hypoxanthine phosphoribosylt
ransferase-1 (Hprt1 mRNA). Total RNA was extracted from
dissected striata with the RNeasy Mini Lipid extraction kit
(Qiagen, Crawely, UK). Five microliters of total RNA was re-
verse transcribed, for 1 hour at 45C, using the AffinityScript
kit (Agilent, Berkshire, UK) in a 25 mL reaction according to
the manufacturer’s instructions. Two microliters of cDNA
was amplified in a 20 mL reaction volume using Brilliant III
ultrafast qPCR master mix reagents (Agilent Technologies).
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PCR products were detected using dual-labeled (FAM/BHQ1)
hybridization probes specific to each of the cDNAs (MWG/
Eurofins, Ebersberg, Germany). The PCR primers were Nrg4
forward: 50-GAG ACA AAC AAT ACC AGA AC-30 and re-
verse: 50-GGA CTG CCA TAG AAA TGA-30; ErbB4 for-
ward: 50-GGC AAT ATC TAC ATC ACT G-30 and reverse:
50-CCA ACA ACC ATC ATT TGA A-30; Gapdh forward: 50-
GAG AAA CCT GCC AAG TAT G-30 and reverse: 50-GGA
GTT GCT GTT GAA GTC-30; Sdha forward: 50-GGA ACA
CTC CAA AAA CAG-30 and reverse: 50-CCA CAG CAT
CAA ATT CAT-30; and Hprt1 forward: 50-TTA AGC AGT
ACA GCC CCA AAA TG-30 and reverse: 50-AAG TCT GGC
CTG TAT CCA ACA C-30. Dual-labeled probes were Nrg4:
50-FAM-CGT CAC AGC CAC AGA GAA CAC-BHQ1-30;
ErbB4: 50-FAM-AGC AAC CTG TGT TAT TAC CAT ACC
ATT-BHQ1-30; Gapdh: 50-FAM-AGA CAA CCT GGT CCT
CAG TGT-BHQ1-3; Sdha: 50-FAM-CCT GCG GCT TTC
ACT TCT CT-BHQ1-3; and Hrpt1: 50-FAM-TCG AGA GGT
CCT TTT CAC CAG CAA G-BHQ1-30. Forward and reverse
primers were used at a concentration of 250 nM and dual-la-
beled probes were used at a concentration of 500 nM. PCR
was performed using the Mx3000P platform (Agilent) using
the following conditions: 95C for 3 minutes followed by 45
cycles of 95C for 10 seconds and 60C for 35 seconds. Stan-
dard curves were generated for each cDNA for every real time
PCR run, by using serial 3-fold dilutions of reverse transcribed
adult mouse brain total RNA (Zyagen, San Diego, CA). Rela-
tive mRNA levels were quantified in the striatum dissected
from 4 animals at each age. Primer and probe sequences were
designed using Beacon Designer software (Premier Biosoft,
Palo Alto, CA).
Golgi Staining
Modified Golgi-Cox impregnation of neurons was per-
formed using the FD Rapid GolgiStain kit (FD NeuroTechnol-
ogies, Columbia, MD) according to the manufacturer’s
instructions on 100 lm sagittal sections of P9, juvenile (P30),
and adult (P60) mouse brains of Nrg4þ/þ and Nrg4/ litter-
mates. Total dendrite length, branch point number and Sholl
analysis was carried out using the plugin Sholl Analysis of Fiji
software (24) after neuronal reconstruction with the plugin
Simple Neurite Tracer (25). The number of spines in 100 lm
dendrite lengths chosen at random was counted and each den-
dritic spine was classified on the basis of accepted morphol-
ogy into 1 of 2 types: immature (either filopolial or thin) and
mature (either stubby, mushroom or branched) (26).
RESULTS
Expression of Nrg4 and ErbB4 Transcripts in the
Developing Striatum
To begin to explore the possibility that NRG4 functions
in the developing striatum, we used qPCR to investigate if
transcripts encoding NRG4 and ErbB4, which is a receptor for
most neuregulins, including NRG4, are present in the striatum
dissected at different ages. This revealed that although Nrg4
mRNA and ErbB4 mRNA were detectable in the embryonic
and postnatal striatum at all stages studied, the expression
profiles differed. Whereas Nrg4 mRNA displayed a large in-
crease after E16 and plateaued from E18 onward, ErbB4
mRNA expression peaked at E16 and decreased with age
(Fig. 1).
Striatal MSN Dendrites Are Markedly Stunted in
Neonatal Nrg4/Mice
To investigate the significance of Ngr4 mRNA expres-
sion in the developing striatum, we compared Nrg4/ and
Nrg4þ/þ mice. Golgi preparations of the striatum were ini-
tially examined in postnatal day 9 (P9) mice. These revealed
that the size and complexity of the dendritic arbors of
MSNs were dramatically reduced throughout the striatum in
Nrg4/ mice compared with Nrg4þ/þ littermates (Fig. 2A).
FIGURE 1. Developmental time course of Nrg4 and ErbB4 mRNA expression in the developing striatum. Levels of Nrg4 mRNA
(A) and ErbB4 mRNA (B) in the striatum of wild type mice at different ages relative to the geometric mean of reference mRNAs
(Gapdh, Sdha, and Hprt1 mRNAs). The mean 6 SEM of data from 4 separate sets of dissected striatum at each age are plotted.
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Quantitative analysis carried out on the dendrite compartments
revealed highly significant 2-fold reductions in total dendrite
length (Fig. 2B) and branch point number (Fig. 2C). These
reductions in dendrite length and branching were reflected in the
Sholl analyses of the dendrite arbors (Fig. 2D). These findings
suggest that NRG4 plays a major role in promoting the growth
and elaboration of MSN dendrites in the developing striatum.
To determine whether the pronounced phenotype ob-
served in neonatal Nrg4/ mice is retained into adulthood,
we repeated the Golgi studies in juvenile (P30) and adult
(P60) Nrg4þ/þ and Nrg4/ littermates. In contrast to the clear
and quantifiable differences observed in the striatal MSN den-
drites in postnatal Nrg4þ/þ and Nrg4/ mice, differences in
the size and complexity of these dendrites were not clearly dis-
cernable at later ages (Fig. 3A, B). Unfortunately, the large
size and complexity of MSN dendrites in juvenile and adult
mice and the fact that many of the dendritic arbors were over-
lapping in our Golgi preparations precluded accurate
quantification.
Decreased Number of MSN Dendrite Spines in
Nrg4/Mice
Because of the difficulty of quantifying the size and
complexity of MSN dendrite arbors in older mice, we exam-
ined another parameter of MSN dendrites that can be easily
observed and quantified in developing and mature mice,
namely, dendrite spine number per unit dendrite length and
dendrite spine morphology. High-resolution images of MSN
dendrite spines in Golgi preparations revealed a reduction in
FIGURE 2. Phenotypic changes in MSN dendrites of Nrg4/ mice at P9. (A) Representative low-power images of the striatum
and high-power images of striatal MSNs in Golgi preparations of Nrg4þ/þ and Nrg4/ mice. Scale bar ¼ 50 lm. Quantification
of total dendrite length (B) and number of branch points in the dendrites (C) of striatal MSNs of P9 Nrg4þ/þ and Nrg4/
littermates (D). Sholl plots of the dendrites of these neurons. The mean 6 SEM of data from 90 neurons (from at least 3 different
animals per genotype) are plotted (****p<0.0001, statistical comparison between Nrg4þ/þ and Nrg4/ mice, 2-tailed t-test).
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dendrite spine number per unit dendrite length in Nrg4/
mice compared with and Nrg4þ/þ mice at P9, P30 and P60
(Fig. 4A). Quantification of the number spines in 100 lm
lengths of MSN dendrites chosen at random revealed highly
significant reductions in Nrg4/ mice compared with Nrg4þ/
þ mice at all 3 ages (Fig. 4B). The magnitude of the reduction
was similar at each age (30% reduction), suggesting that this
reduction arises in development and is sustained in the adult.
Because of the reduced total length of MSN dendrite arbors
quantified in neonatal Nrg4/ mice (Fig. 2), the highly signif-
icant reduction in MSN spine number per unit length in
Nrg4/ mice implies an even greater decrease in the total
number of dendrite spines on MSNs in Nrg4/ neonates.
In addition to counting dendritic spine number, we also
classified each spine into immature or mature types depending
on generally accepted morphological criteria (26). While there
were marked increases in the number of mature spines in both
genotypes between P9 and P30, there were significantly fewer
mature spines in Nrg4/ mice compared with and Nrg4þ/þ
mice at P30 and P60 (Fig. 4C). Although there were fewer im-
mature spines than mature spines at all ages in both genotypes,
there were significantly more immature spines in Nrg4þ/þ
mice than Nrg4/ mice at P9 just before the marked increase
in the number of mature spines (Fig. 4C).
MSNs Cultured from Nrg4/ Embryos Have
Stunted Neurites
To ascertain whether the stunted dendrite phenotype ob-
served in developing Nrg4/ mice in vivo is replicated
in vitro and can be rescued by NRG4 treatment, we set up dis-
sociated MSN cultures from Nrg4/ and Nrg4þ/þ littermates.
Cultures were established from E14 striatal primordial and
were fixed and examined 10 days after plating. MSNs were
positively identified using an antibody to dopamine and cyclic
AMP-regulated protein (DARPP-32), which is expressed by
more than 95% of MSNs (27). Cultures were double labeled
with anti-DARPP-32 and anti-bIII tubulin, which labels all
neurons. Quantification showed that 69.8% 6 1.2% (mean 6
SEM) of the cells were positive for DARPP-32.
Similar to the phenotypic changes observed in Golgi
preparations of Nrg4/ mice, the neurite arbors of MSNs cul-
tured from Nrg4/ mice were smaller and less complex than
those of MSNs cultured from Nrg4þ/þ littermates (Fig. 5A).
Measurement of total neurite length and branch point number
confirmed highly significant 2- to 3-fold decreases in neurons
cultured from Nrg4/ mice compared with those cultured
from Nrg4þ/þ littermates (Fig. 5B, C). The differences in the
size and complexity of neurite arbors of neurons cultured from
Nrg4/ and Nrg4þ/þ littermates were reflected in the Sholl
plots of these neurons (Fig. 5D), which provide graphic repre-
sentation of neurite length and branching with distance from
the cell body. The reductions in neurite length and branching
in DARPP-32-positive MSNs cultured from Nrg4/ mice
were completely restored to wild type levels by treatment with
recombinant NRG4 (Fig. 5). These results show that the MSN
phenotype observed in vivo in NRG4-deficient mice is repli-
cated in cultured neurons and is completely rescued by soluble
recombinant NRG4 treatment.
MSNs cultured from wild type embryos responded with
increased neurite growth and branching to NRG4 in a dose-
dependent manner (Supplementary Data Fig. S1). This sug-
gests that endogenous synthesis of NRG4, at least in culture, is
not saturating.
FIGURE 3. MSNs of juvenile (P30) and adult (P60) Nrg4þ/þ and Nrg4/ mice. Representative low-power images of the striatum
(A) and high-power images of MSNs (B) of Golgi preparations of Nrg4þ/þ and Nrg4/ mice. Scale bars ¼ 50 lm for A and
10 lm for B. Samples from at least 3 animals per genotype were analyzed.
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MSNs Coexpress NRG4 and ErbB4
To ascertain the identity of the cells that produce NRG4
in striatum, we studied NRG4 immunofluorescence in dissoci-
ated MSN cultures. Double labeling for NRG4 and the specific
MSN marker DARPP-32 revealed that 74.72% 6 8.7% of the
DARPP-32-positive cells were colabeled with anti-NRG4
(Fig. 6A, E). In double labeling experiments using anti-
DARPP-32 and anti-ErbB4, 67.82% 6 13% of the DARPP-
32-positive cells were also colabeled with anti-ErbB4
(Fig. 6B, E). These observations suggest that most MSNs
coexpress NRG4 and ErbB4. To formally demonstrate coex-
pression, we double labeled MSN cultures with antibodies to
NRG4 and ErbB4. Accordingly, 97.33% 6 6.26% of neurons
that were immunopositive for NRG4 were also immunoposi-
tive for ErbB4 (Fig. 6C). NRG4 immunoreactivity was not ob-
served in cultures established from Nrg4/ mice,
demonstrating the specificity of the anti-NRG4 antibody
(Fig. 6D). Taken together, these findings suggest that most
MSNs coexpress NRG4 and ErbB4 and raise the possibility
that NRG4 exerts its effects on MSNs by an autocrine/para-
crine mechanism.
While immunohistochemical expression of ErbB4 in
striatum has been reported (28), we also demonstrated NRG4
immunolabeling and overlapping DARPP-32 immunolabeling
in sections of the striatum, which provides an additional dem-
onstration of NRG4 protein expression in the striatum (Sup-
plementary Data Fig. S2). NRG4 immunolabeling was absent
in the striatum of Nrg4/ mice, further demonstrating the
specificity of the anti-NRG4 antibody.
DISCUSSION
Striatal MSNs comprise a large, clinically important
population of neurons that are extensively connected with
FIGURE 4. Reduction in MSN dendrite spine density in Nrg4/ mice. (A) Representative images showing the dendritic spines of
Nrg4þ/þ and Nrg4/ mice at P9, P30, and P60. Scale bar ¼ 10 lm. (B) Quantification of the total number of spines at different
ages from Nrg4þ/þ and Nrg4/ mice. Mean of total number 6 SEM from 150 independent 100 lm segments from different
neurons per genotype (***p<0.001 and ****p<0.0001, one-way ANOVA with Tukey’s multiple comparison post hoc test). (C)
Quantification of immature (filopodia and long thin) and mature (stubby, mushroom and branched) spines of dendrites of
Nrg4þ/þ and Nrg4/ mice at P9, P30, and P60 (ns, not significant, *p<0.05, ***p<0.001, one-way ANOVA with Fisher’s
multiple comparison post hoc test).
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several major brain regions. Characteristic changes in the
exuberant dendritic arbors and spine density of these neurons
have been described in many neurological conditions and are
also caused by a variety of recreational and medicinal drugs
(2, 4–10). Despite this wealth of observational data, the physi-
ological regulators of the growth and elaboration of MSN den-
drites and the regulators of dendritic spine formation on these
neurons remain poorly understood. Here, we report that NRG4
is a major novel, physiologically relevant regulator of MSN
dendrite growth and elaboration and MSN dendrite spine for-
mation and maturation. We have shown that neonatal mice
that lack NRG4 have markedly stunted MSN dendritic arbors
compared with wild type littermates. NRG4-deficient neo-
nates displayed highly significant reductions in total dendrite
length and in dendrite branching. While dendrite arbor size
and complexity could not be clearly quantified at later stages,
a limitation of this aspect of our study, juvenile and adult
NRG4-deficient mice nonetheless displayed a highly
FIGURE 5. The phenotype of striatal MSNs of Nrg4/ mice is replicated in culture and is rescued by recombinant NRG4. (A)
Representative photomicrographs of striatal MSNs of E14 Nrg4þ/þ and Nrg4/ mice cultured for 10 days. Cultures were
supplemented with 100 ng/mL recombinant NRG4 at plating, as indicated. Neurons were double labeled for bIII-tubulin (red)
and DARPP-32 (green) to identify MSNs. Scale bar ¼ 25 lm. Total neurite length (B), branch point number (C), and Sholl plots
(D) of MSNs in these cultures are shown. Mean 6 SEM of data collected from 3 independent experiments (****p<0.0001, one-
way ANOVA with Tukey’s multiple comparison post hoc test).
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significant reduction in MSN dendrite spine number per unit
dendrite length compared with wild type mice. This signifi-
cant decrease was already evident in NRG4-deficient neo-
nates, showing that it arises in development and remains
substantially unchanged as nervous system matures. In addi-
tion to the marked reduction in the number of MSN dendrite
spines in Nrg4/ mice, there was a significant reduction in
the proportion of spines that exhibited a mature morphology
in juvenile and adult Nrg4/ mice. These results show that
NRG4 plays an important physiological role in contributing to
the formation and maturation of MSN dendrite spines.
The neuregulin family of secreted growth factors has a
multitude of functions in a variety of tissues and has a particu-
larly extensive repertoire of roles in the nervous system in de-
velopment, health and disease (16–22). NRG4 is atypical in
that it is expressed in a limited number of adult tissues and has
been reported to have negligible expression in adult brain com-
pared with other neuregulins (29, 30). Perhaps because of this,
its potential neural functions have received little attention. In-
deed, only one function has been described for NRG4 in the
brain, that of promoting the growth and elaboration of pyrami-
dal dendrites in the developing mouse neocortex (23). How-
FIGURE 6. Cultured striatal MSNs coexpress NRG4 and ErbB4. (A–C) Representative photomicrographs of MSNs of E14 embryos
cultured for 10 days and double labeled with antibodies to DARPP-32 and NRG4 (A), DARPP-32 and ErbB4 (B), or NRG4 and
ErbB4 (C). To demonstrate the specificity of the anti-NRG4 antibody, cultures were set up from E14 Nrg4/ embryos, in which
NRG4 immunoreactivity was not observed (D). To identify nuclei, all cultures were counterstained with DAPI. Scale bar ¼ 20 lm.
(E) Quantification of the number of positive neurons for NRG4 and ErbB4, DARPP-32 and NRG4, and DARPP-32 and ErbB4. Data
are % positive neurons 6 SEM from least 90 neurons collected from 3 independent experiments.
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ever, it has yet to be investigated whether cortical pyramidal
neurons in Nrg4/ mice, like MSNs, also have a deficit in
dendritic spines. In the peripheral nervous system, it has re-
cently been reported that NRG4 is a physiological regulator of
sympathetic axon growth and regulates adipose tissue innerva-
tion (31).
The marked dendrite phenotype of MSNs observed in
Nrg4/ mice could result from either the loss of a direct
action of endogenous NRG4 on MSNs or an indirect effect of
the absence of NRG4. Several observations suggest that
NRG4 acts directly on developing MSNs. First, we have
shown that most MSNs express ErbB4, the principal NRG4 re-
ceptor tyrosine kinase, and thus have the capacity to respond
to NRG4 directly. Second, in dissociated culture, in which
MSNs no longer retain their characteristic rich connections
with other neurons, they nonetheless extend shorter, less
branched neurites when cultured from Nrg4/ embryos, com-
pared with Nrg4þ/þ embryos. This suggests that the stunted
neurite arbors of MSNs cultured from NRG4-deficient em-
bryos is not dependent on their connections with other neu-
rons. Third, the stunted neurites of MSNs cultured from
Nrg4/ embryos can be restored in size and complexity to
those of MSNs cultured from Nrg4þ/þ embryos by NRG4
treatment. This not only suggests that MSNs are able to re-
spond to NRG4 directly but also suggests that no indirect ef-
fect of NRG4 is needed to account for the stunted in vivo
dendrite phenotype of MSNs of Nrg4/ mice since the rescue
of the in vitro phenotype is complete.
The coexpression of NRG4 and ErbB4 on MSNs, at least
in culture, raises the possibility that NRG4 exerts its effects on
MSNs in vivo by an autocrine mechanism. Likewise, neocorti-
cal pyramidal neurons coexpress NRG4 and ErbB4, raising the
possibility that NRG4 acts on these neurons by an autocrine
route (23). NRG1 autocrine signaling promotes remyelination
following peripheral nerve injury (32), and an ErbB4/NRG2
autocrine signaling loop has been reported in inhibitory inter-
neurons (33). Neuregulin autocrine signaling has also been im-
plicated outside the nervous system, for example, in
promoting the proliferation of certain cancers (34).
In addition to autocrine NRG4, MSNs may also obtain
NRG4 from the neurons with which they synapse. MSNs proj-
ect to globus pallidus and midbrain (2), and the report that
Nrg4 mRNA is expressed in the newborn midbrain (23) raises
the possibility that MSNs may obtain NRG4 by a retrograde
paracrine route from this target. MSNs receive afferents from
several brain regions (1), and the report that Nrg4 mRNA is
detectable in the cerebral cortex of newborn mice (23) raises
the possibility that MSNs may obtain NRG4 by an anterograde
paracrine route. There is, for example, evidence that MSNs
may obtain BDNF from the cerebral cortex by an anterograde
route (35).
In summary, our in vivo studies of striatal MSNs show
that NRG4 is a prominent novel physiological regulator of the
growth and elaboration of MSN dendrites and the formation
and maturation of dendritic spines. Furthermore, our in vitro
studies suggest that NRG4 acts directly on MSNs during de-
velopment. This work raises several important questions for
future research, namely, whether the striking morphological
phenotype of MSNs in NRG4-deficient mice is accompanied
by a behavioral phenotype and whether there are additional
functional changes in NRG4-deficient MSNs that are not di-
rectly related to the morphological phenotype.
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